Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP synthase F0 complex subunit C3, encoded by the ATP5MC3 gene, is a critical component of the mitochondrial F1F0 ATP synthase (Complex V). It forms part of the transmembrane c-ring within the F0 domain, which functions as a rotary proton channel driven by the electrochemical gradient across the inner mitochondrial membrane (UniProt P48201). The rotation of this c-ring is mechanically coupled to the F1 catalytic domain, enabling the synthesis of ATP from ADP and inorganic phosphate (PubMed: 29162618). In humans, this subunit is one of three isoforms (along with C1 and C2) that are identical or nearly identical in protein sequence and contribute to the same functional enzyme complex (HGNC: 843). Pathologically, the failure to properly degrade this proteolipid leads to its accumulation in lysosomes, a hallmark of Neuronal Ceroid Lipofuscinosis or Batten disease (PubMed: 1554493). While it is a target for potent inhibitors like oligomycin, which are used extensively in metabolic research, its essential role in life makes it a challenging target for systemic human therapeutics due to the risk of global metabolic failure. However, it remains a subject of intense study in the context of mitochondrial diseases, cancer metabolism, and the regulation of the mitochondrial permeability transition pore.
Inhibition of the F0 proton channel by binding to the c-ring subunits, which physically blocks proton translocation across the inner mitochondrial membrane and halts the rotation of the ATP synthase enzyme, thereby preventing the phosphorylation of ADP to ATP.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase F0 complex subunit C3 (ATP5MC3).